Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 180
Filtrar
1.
J Med Chem ; 67(8): 6822-6838, 2024 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-38588468

RESUMEN

Weak antigens represented by MUC1 are poorly immunogenic, which greatly constrains the development of relevant vaccines. Herein, we developed a multifunctional lipidated protein as a carrier, in which the TLR1/2 agonist Pam3CSK4 was conjugated to the N-terminus of MUC1-loaded carrier protein BSA through pyridoxal 5'-phosphate-mediated transamination reaction. The resulting Pam3CSK4-BSA-MUC1 conjugate was subsequently incorporated into liposomes, which biomimics the membrane structure of tumor cells. The results indicated that this lipidated protein carrier significantly enhanced antigen uptake by APCs and obviously augmented the retention of the vaccine at the injection site. Compared with the BSA-MUC1 and BSA-MUC1 + Pam3CSK4 groups, Pam3CSK4-BSA-MUC1 evoked 22- and 11-fold increases in MUC1-specific IgG titers. Importantly, Pam3CSK4-BSA-MUC1 elicited robust cellular immunity and significantly inhibited tumor growth. This is the first time that lipidated protein was constructed to enhance antigen immunogenicity, and this universal carrier platform exhibits promise for utilization in various vaccines, holding the potential for further clinical application.


Asunto(s)
Liposomas , Mucina-1 , Animales , Mucina-1/inmunología , Mucina-1/química , Ratones , Humanos , Lipopéptidos/química , Lipopéptidos/inmunología , Lipopéptidos/farmacología , Vacunas contra el Cáncer/inmunología , Vacunas contra el Cáncer/química , Albúmina Sérica Bovina/química , Adyuvantes Inmunológicos/farmacología , Adyuvantes Inmunológicos/química , Femenino , Ratones Endogámicos BALB C , Antígenos/inmunología , Línea Celular Tumoral
2.
Bioconjug Chem ; 32(8): 1472-1490, 2021 08 18.
Artículo en Inglés | MEDLINE | ID: mdl-34228433

RESUMEN

The development of lipopeptides (lipidated peptides) for vaccines is discussed, including their role as antigens and/or adjuvants. Distinct classes of lipopeptide architectures are covered including simple linear and ligated constructs and lipid core peptides. The design, synthesis, and immunological responses of the important class of glycerol-based Toll-like receptor agonist lipopeptides such as Pam3CSK4, which contains three palmitoyl chains and a CSK4 hexapeptide sequence, and many derivatives of this model immunogenic compound are also reviewed. Self-assembled lipopeptide structures including spherical and worm-like micelles that have been shown to act as vaccine agents are also described. The work discussed includes examples of lipopeptides developed with model antigens, as well as for immunotherapies to treat many infectious diseases including malaria, influenza, hepatitis, COVID-19, and many others, as well as cancer immunotherapies. Some of these have proceeded to clinical development. The research discussed highlights the huge potential of, and diversity of roles for, lipopeptides in contemporary and future vaccine development.


Asunto(s)
Lipopéptidos/química , Vacunas/química , Animales , Humanos , Lipopéptidos/inmunología , Vacunas/inmunología
3.
Theranostics ; 11(15): 7425-7438, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34158858

RESUMEN

The lack of tumor specific antigens (TSA) and the immune tolerance are two major obstacles for the immunotherapy of cancer. Current immune checkpoint inhibitors (ICIs) show clinical responses in only limited subsets of cancer patients, which, to some extent, depends on the mutation load of tumor cells that may generate neoantigens. Here, we aimed to generate a neoantigen MDP to exhibit stronger anti-tumor efficacy. Methods: In this study, we utilized chemically modified sialic acid precursor tetra acetyl-N-azidoacetyl-mannosamine (AC4ManNAZ) to engineer the glycoproteins on the membranes of tumor cells for the covalent ligation of hapten adjuvant Pam3CSK4 in vivo, which eventually generated a neoantigen, i.e., ManNAZ-DBCO-Pam3CSK4 (MDP), on tumor cells. The high labeling efficiency, relatively specific biodistribution in tumor tissues and the anti-tumor efficacy were confirmed in the syngeneic murine models of the breast cancer and the lung cancer. Results: The generation of MDP neoantigen in tumor-bearing mice significantly evoked both the humoral and the T-cell-dependent antitumor immune responses, resulting in a strong inhibition on the growth of the breast cancer and the lung cancer allografts and significantly prolonged survival of tumor-bearing mice. Interestingly, MDP neoantigen was able to dramatically increase the sensitivity of cancer cells to ICIs and greatly enhance the anti-tumor efficacy in the murine models of both breast cancer and the lung cancer, which showed no or low responses to the immunotherapy with anti-PD1 antibody alone. Conclusions: We developed a simple metabolic glycoengineering method to artificially generate neoantigens on tumor cells to enhance tumor cell immunogenicity, which is able to significantly improve the response and the clinical outcome of ICIs.


Asunto(s)
Antígenos de Neoplasias , Vacunas contra el Cáncer , Glicoproteínas , Lipopéptidos , Neoplasias Mamarias Experimentales , Animales , Antígenos de Neoplasias/química , Antígenos de Neoplasias/inmunología , Antígenos de Neoplasias/farmacología , Vacunas contra el Cáncer/química , Vacunas contra el Cáncer/inmunología , Vacunas contra el Cáncer/farmacología , Línea Celular Tumoral , Femenino , Glicoproteínas/química , Glicoproteínas/inmunología , Glicoproteínas/farmacología , Lipopéptidos/química , Lipopéptidos/inmunología , Lipopéptidos/farmacología , Neoplasias Mamarias Experimentales/inmunología , Neoplasias Mamarias Experimentales/terapia , Ratones
4.
Sci Rep ; 11(1): 6782, 2021 03 24.
Artículo en Inglés | MEDLINE | ID: mdl-33762618

RESUMEN

Following bacterial infection, macrophages produce pro-inflammatory cytokines in response to bacterial cell components, including lipopolysaccharide (LPS) and lipopeptide, and simultaneously phagocytize and digest the invading bacteria. To study the effects of phagocytosis on pro-inflammatory responses, we determined if phagocytosis of polystyrene latex beads with ~ 1 µm diameter increases pro-inflammatory cytokine expression by human macrophage-like U937 and THP-1 cells stimulated with LPS. Treating macrophage-like cells with beads coated with IgG to facilitate Fcγ receptor-mediated phagocytosis increased LPS-induced expression of pro-inflammatory cytokines, including tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. Treatment with beads coated with poly-L-lysine to facilitate Fcγ receptor-independent phagocytosis also increased LPS-induced cytokine expression. Our results indicate that LPS-induced pro-inflammatory responses are enhanced by bead phagocytosis regardless of the uptake mechanism. Additionally, phagocytosis enhanced LPS-induced NF-κB activation, suggesting that Toll-like receptor (TLR) 4 signaling is enhanced by phagocytosis. Furthermore, bead phagocytosis enhanced pro-inflammatory responses in U937 cells stimulated with lipopeptide, a ligand for the TLR2/TLR6 heterodimeric receptor. In conclusion, microparticle phagocytosis by macrophage-like U937 and THP-1 cells enhances the innate immune response induced by bacterial components.


Asunto(s)
Antígenos Bacterianos/inmunología , Lipopéptidos/inmunología , Lipopolisacáridos/inmunología , Macrófagos/inmunología , Macrófagos/metabolismo , Fagocitosis/inmunología , Animales , Citocinas/metabolismo , Interacciones Huésped-Patógeno/inmunología , Humanos , Mediadores de Inflamación/metabolismo , FN-kappa B/metabolismo , Receptores de IgG/metabolismo , Células THP-1 , Células U937
5.
Nat Commun ; 12(1): 1836, 2021 03 23.
Artículo en Inglés | MEDLINE | ID: mdl-33758175

RESUMEN

To prevent damage to the host or its commensal microbiota, epithelial tissues must match the intensity of the immune response to the severity of a biological threat. Toll-like receptors allow epithelial cells to identify microbe associated molecular patterns. However, the mechanisms that mitigate biological noise in single cells to ensure quantitatively appropriate responses remain unclear. Here we address this question using single cell and single molecule approaches in mammary epithelial cells and primary organoids. We find that epithelial tissues respond to bacterial microbe associated molecular patterns by activating a subset of cells in an all-or-nothing (i.e. digital) manner. The maximum fraction of responsive cells is regulated by a bimodal epigenetic switch that licenses the TLR2 promoter for transcription across multiple generations. This mechanism confers a flexible memory of inflammatory events as well as unique spatio-temporal control of epithelial tissue-level immune responses. We propose that epigenetic licensing in individual cells allows for long-term, quantitative fine-tuning of population-level responses.


Asunto(s)
Bacterias/inmunología , Células Epiteliales/inmunología , Inmunidad Innata , Lipopéptidos/inmunología , FN-kappa B/metabolismo , Receptor Toll-Like 2/metabolismo , Animales , Bacterias/metabolismo , Línea Celular , Citocinas/metabolismo , Citocinas/farmacología , Metilación de ADN/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Flagelina/farmacología , Regulación de la Expresión Génica/genética , Regulación de la Expresión Génica/inmunología , Humanos , Procesamiento de Imagen Asistido por Computador , Inmunidad Innata/efectos de los fármacos , Inmunidad Innata/genética , Hibridación Fluorescente in Situ , Glándulas Mamarias Animales , Ratones , Organoides/efectos de los fármacos , Organoides/inmunología , Organoides/metabolismo , Regiones Promotoras Genéticas , RNA-Seq , Transducción de Señal/inmunología , Análisis de la Célula Individual , Receptor Toll-Like 2/agonistas , Receptor Toll-Like 2/genética , Receptores Toll-Like/agonistas , Receptores Toll-Like/metabolismo
6.
Chembiochem ; 22(7): 1215-1222, 2021 04 06.
Artículo en Inglés | MEDLINE | ID: mdl-33180981

RESUMEN

Synthetic vaccines, based on antigenic peptides that comprise MHC-I and MHC-II T-cell epitopes expressed by tumors, show great promise for the immunotherapy of cancer. For optimal immunogenicity, the synthetic peptides (SPs) should be adjuvanted with suitable immunostimulatory additives. Previously, we have shown that improved immunogenicity in vivo is obtained with vaccine modalities in which an SP is covalently connected to an adjuvanting moiety, typically a ligand to Toll-like receptor 2 (TLR2). SPs were covalently attached to UPam, which is a derivative of the classic TLR2 ligand Pam3 CysSK4 . A disadvantage of the triply palmitoylated UPam is its high lipophilicity, which precludes universal adoption of this adjuvant for covalent modification of various antigenic peptides as it renders the synthetic vaccine insoluble in several cases. Here, we report a novel conjugatable TLR2 ligand, mini-UPam, which contains only one palmitoyl chain, rather than three, and therefore has less impact on the solubility and other physicochemical properties of a synthetic peptide. In this study, we used SPs that contain the clinically relevant neoepitopes identified in a melanoma patient who completely recovered after T-cell therapy. Homogeneous mini-UPam-SP conjugates have been prepared in good yields by stepwise solid-phase synthesis that employed a mini-UPam building block pre-prepared in solution and the standard set of Fmoc-amino acids. The immunogenicity of the novel mini-UPam-SP conjugates was demonstrated by using the cancer patient's T-cells.


Asunto(s)
Antígenos de Neoplasias/química , Vacunas contra el Cáncer/inmunología , Ligandos , Receptor Toll-Like 2/química , Vacunas Sintéticas/inmunología , Antígenos de Neoplasias/inmunología , Vacunas contra el Cáncer/química , Línea Celular , Células Dendríticas/citología , Células Dendríticas/metabolismo , Diseño de Fármacos , Humanos , Interleucina-8/metabolismo , Lipopéptidos/síntesis química , Lipopéptidos/química , Lipopéptidos/inmunología , Lipoilación , Activación de Linfocitos , Receptor Toll-Like 2/metabolismo , Vacunas Sintéticas/química
7.
Front Immunol ; 11: 588180, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33281817

RESUMEN

Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a chronic disease of cattle with a detrimental impact on food quality and production. Research on bTB vaccines has predominantly been focused on proteinaceous antigens. However, mycobacteria have a thick and intricate lipid outer layer and lipids as well as lipopeptides are important for immune-evasion and virulence. In humans, lipid extracts of M. tuberculosis have been shown to elicit immune responses effective against M. tuberculosisin vitro. Chloroform-methanol extraction (CME) was applied to M. bovis BCG to obtain a hydrophobic antigen extract (CMEbcg) containing lipids and lipopeptides. CMEbcg stimulated IFN-γ+IL-2+ and IL-17A+IL-22+ polyfunctional T cells and elicited T cell responses with a Th1 and Th17 cytokine release profile in both M. bovis BCG vaccinated and M. bovis challenged calves. Lipopeptides were shown to be the immunodominant antigens in CMEbcg, stimulating CD4 T cells via MHC class II. CMEbcg expanded T cells killed CMEbcg loaded monocytes and the CMEbcg-specific CD3 T cell proliferative response following M. bovis BCG vaccination was the best predictor for reduced pathology following challenge with M. bovis. Although the high predictive value of CMEbcg-specific immune responses does not confirm a causal relationship with protection against M. bovis challenge, when taking into account the in vitro antimycobacterial phenotype of CMEbcg-specific T cells (e.g. Th1/Th17 cytokine profile), it is indicative that CMEbcg-specific immune responses could play a functional role in immunity against M. bovis. Based on these findings we conclude that lipopeptides of M. bovis are potential novel subunit vaccine candidates and that further studies into the functional characterization of lipopeptide-specific immune responses together with their role in protection against bovine tuberculosis are warranted.


Asunto(s)
Antígenos Bacterianos/inmunología , Vacuna BCG/administración & dosificación , Lipopéptidos/inmunología , Mycobacterium bovis/inmunología , Linfocitos T/inmunología , Vacunas de Subunidad/administración & dosificación , Animales , Anticuerpos Antibacterianos/inmunología , Bovinos/inmunología , Citocinas/inmunología , Interacciones Hidrofóbicas e Hidrofílicas , Inmunización , Masculino
8.
Bioorg Med Chem ; 28(24): 115823, 2020 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-33120079

RESUMEN

In order to improve the immunogenicity of peptide-based vaccines against group A Streptococcus (GAS), lipid moieties (C16 lipoamino acid and cholic acid) were conjugated with peptide antigen (P25-J8) and further modified with α-poly(glutamic acid) (α-PGA). Thus, positively charged lipopeptide vaccine candidates LCP-1 (P25-K(J8)-SS-C16-C16) and LCP-2 (P25-K(J8)-SS-K(cholic acid)) were synthesized. Negatively charged LCP-3 (P25-K(PGA-J8)-SS-K(cholic acid)) was also produced by attaching α-PGA to the J8 N-terminus of LCP-2. Polyelectrolyte complex (PEC) nanoparticles were formulated with heparin and/or trimethyl chitosan (TMC) for delivery of the lipopeptide vaccine candidates. The ability of the antigen-loaded nanoparticles to induce humoral immune responses was examined in outbred female Swiss mice following intranasal immunization. The antibodies produced were opsonic against all clinical GAS isolates tested.


Asunto(s)
Lipopéptidos/inmunología , Streptococcus pyogenes/inmunología , Vacunas de Subunidad/inmunología , Adyuvantes Inmunológicos , Administración Intranasal , Animales , Anticuerpos/inmunología , Línea Celular , Supervivencia Celular/efectos de los fármacos , Quitosano/química , Homólogo de la Proteína Chromobox 5 , Femenino , Humanos , Inmunidad Humoral , Lipopéptidos/administración & dosificación , Lipopéptidos/química , Lipopéptidos/farmacología , Ratones , Nanopartículas/química , Polielectrolitos/química , Ácido Poliglutámico/química , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/prevención & control , Vacunas de Subunidad/administración & dosificación , Vacunas de Subunidad/química , Vacunas de Subunidad/farmacología
9.
Viruses ; 12(10)2020 10 06.
Artículo en Inglés | MEDLINE | ID: mdl-33036278

RESUMEN

The highly conserved extracellular domain of the transmembrane protein M2 (M2e) of the influenza A virus is a promising target for the development of broad-spectrum vaccines. However, M2e is a poor immunogen by itself and must be linked to an appropriate carrier to induce an efficient immune response. In this study, we obtained recombinant mosaic proteins containing tandem copies of M2e fused to a lipopeptide from Neisseria meningitidis surface lipoprotein Ag473 and alpha-helical linkers and analyzed their immunogenicity. Six fusion proteins, comprising four or eight tandem copies of M2e flanked by alpha-helical linkers, lipopeptides, or a combination of both of these elements, were produced in Escherichia coli. The proteins, containing both alpha-helical linkers and lipopeptides at each side of M2e repeats, formed nanosized particles, but no particulate structures were observed in the absence of lipopeptides. Animal study results showed that proteins with lipopeptides induced strong M2e-specific antibody responses in the absence of external adjuvants compared to similar proteins without lipopeptides. Thus, the recombinant M2e-based proteins containing alpha-helical linkers and N. meningitidis lipopeptide sequences at the N- and C-termini of four or eight tandem copies of M2e peptide are promising vaccine candidates.


Asunto(s)
Proteínas Bacterianas/inmunología , Virus de la Influenza A/inmunología , Proteínas de la Fusión de la Membrana/inmunología , Proteínas Recombinantes de Fusión/inmunología , Vacunas Sintéticas/inmunología , Proteínas de la Matriz Viral/inmunología , Animales , Modelos Animales de Enfermedad , Femenino , Humanos , Vacunas contra la Influenza/inmunología , Gripe Humana/prevención & control , Lipopéptidos/inmunología , Ratones , Ratones Endogámicos BALB C , Nanopartículas/química , Neisseria meningitidis/inmunología , Infecciones por Orthomyxoviridae/prevención & control , Dominios Proteicos/inmunología
10.
Int Immunol ; 32(12): 805-810, 2020 11 23.
Artículo en Inglés | MEDLINE | ID: mdl-32720986

RESUMEN

The covalent conjugation of a 14-carbon fatty acid (myristic acid) to the N-terminal Gly residue, termed N-myristoylation, occurs in some viral proteins to dictate their pathological function. This protein lipidation reaction, however, is monitored by host cytotoxic T lymphocytes that are capable of recognizing N-terminal lipopeptide fragments in the context of major histocompatibility complex (MHC) class I molecules. In a rhesus model of human AIDS, for example, the classical MHC class I allomorph, Mamu-B*05104, was shown to bind SIV Nef-derived 4-mer lipopeptides (myristic acid-Gly-Gly-Ala-Ile; C14nef4) and present them to the CD8+ T-cell line, SN45. These lipopeptides accommodated in MHC class I molecules expose much shorter peptide chains than conventional MHC class I-presented 8-10-mer peptides, and the molecular mechanisms by which αß T-cell receptors (TCRs) recognize lipopeptides currently remain unclear. An X-ray crystallographic analysis of the SN45 TCR α and ß heterodimer in a form that was co-crystallized with the C14nef4-bound Mamu-B*05104 complex indicated that the amide group of the N-myristoylated glycine residue offered a primary T-cell epitope by establishing a sole hydrogen bond between its nitrogen atom and the side chain of Glu at position 101 of CDR3ß. Accordingly, the Glu to Ala mutation at this position resulted in the loss of lipopeptide recognition. On the other hand, TCRs were positioned remotely from the peptide portion of C14nef4, and strong interactions were not observed. Thus, these observations provide novel structural insights into lipopeptide recognition by TCRs, which contrast sharply with the general molecular principle of peptide recognition.


Asunto(s)
Antígenos de Histocompatibilidad Clase I/química , Lipopéptidos/química , Receptores de Antígenos de Linfocitos T/química , Cristalografía por Rayos X , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Lipopéptidos/inmunología , Modelos Moleculares , Conformación Proteica , Receptores de Antígenos de Linfocitos T/inmunología
11.
Vaccine ; 38(3): 597-607, 2020 01 16.
Artículo en Inglés | MEDLINE | ID: mdl-31740096

RESUMEN

To facilitate the preparation of synthetic epitope-based self-adjuvanting vaccines capable of eliciting antibody responses in an out-bred population, we have developed two modular approaches. In the first, the Toll-like receptor 2 agonist Pam2Cys and the target antibody epitope are assembled as a module which is then coupled to a carrier protein as a source of antigens to stimulate T cell help. A vaccine candidate made in this way was shown to induce a specific immune response in four different strains of mice without the need for extraneous adjuvant. In the second approach, three vaccine components in the form of a target antibody epitope, a T helper cell epitope and Pam2Cys, were prepared separately each carrying different chemical functional groups. By using pH-mediated chemo-selective ligations, the vaccine was assembled in a one-pot procedure. Using this approach, a number of vaccine constructs including a lipopeptide-protein conjugate were made and also shown to elicit immune responses in different strains of mice. These two modular approaches thus constitute a powerful platform for the assembly of self-adjuvanting lipopeptide-based vaccines that can potentially be used to induce robust antibody responses in an outbred population. Finally, our study of the impact of chemical linkages on immunogenicity of a lipopeptide vaccine shows that a stable covalent bond between Pam2Cys and a B cell epitope, rather than between Pam2Cys and T helper cell epitope is critical for the induction of antibody responses and biological efficacy, indicating that Pam2Cys functions not only as an adjuvant but also participates in processing and presentation of the immunogen.


Asunto(s)
Adyuvantes Inmunológicos/síntesis química , Química Farmacéutica/métodos , Lipopéptidos/síntesis química , Vacunas de Subunidad/síntesis química , Vacunas Sintéticas/química , Adyuvantes Inmunológicos/administración & dosificación , Secuencia de Aminoácidos , Animales , Femenino , Lipopéptidos/administración & dosificación , Lipopéptidos/inmunología , Masculino , Ratones , Linfocitos T Colaboradores-Inductores/efectos de los fármacos , Linfocitos T Colaboradores-Inductores/inmunología , Vacunas de Subunidad/administración & dosificación , Vacunas de Subunidad/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/inmunología
12.
J Infect Dis ; 221(6): 934-942, 2020 03 02.
Artículo en Inglés | MEDLINE | ID: mdl-31621864

RESUMEN

BACKGROUND: The human hookworm, Necator americanus, is a parasite that infects almost half a billion people worldwide. Although treatment is available, vaccination is favorable to combat the spread of this parasite due to its wide distribution and continuous reinfection cycle in endemic communities. METHODS: We have designed a lipopeptide oral delivery system using a B-cell epitope derived from the aspartic protease Na-APR-1 from N americanus, attached to a T-helper epitope. Lipopeptides were self-assembled into nanoparticles or entrapped in liposomes that were electrostatically coated with alginate and trimethyl chitosan polymer shields. The adjuvant-free vaccine candidates were orally administered to mice and generated a humoral immune response against both peptide antigen, and the parent protein in the hookworm gut. RESULTS: The vaccine candidates were evaluated in a rodent hookworm challenge model, resulting in up to 98% and 99% decreases in mean intestinal worm and egg burdens in immunized mice, respectively. CONCLUSIONS: Lipopeptide survived the gastrointestinal conditions, induced humoral immune responses and drived protection against parasite challenge infection.


Asunto(s)
Infecciones por Uncinaria/prevención & control , Lipopéptidos/inmunología , Vacunas/inmunología , Animales , Infecciones por Uncinaria/parasitología , Inmunidad Humoral , Lipopéptidos/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Necator americanus/metabolismo , Vacunación
13.
J Med Chem ; 62(17): 8080-8089, 2019 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-31373811

RESUMEN

Tuberculosis (TB) remains a staggering burden on global public health. Novel preventative tools are desperately needed to reach the targets of the WHO post-2015 End-TB Strategy. Peptide or protein-based subunit vaccines offer potential as safe and effective generators of protection, and enhancement of local pulmonary immunity may be achieved by mucosal delivery. We describe the synthesis of a novel subunit vaccine via native chemical ligation. Two immunogenic epitopes, ESAT61-20 and TB10.43-11 from Mycobacterium tuberculosis (Mtb), were covalently conjugated to the TLR2-ligand Pam2Cys to generate a self-adjuvanting lipopeptide vaccine. When administered mucosally to mice, the vaccine enhanced pulmonary immunogenicity, inducing strong Th17 responses in the lungs and multifunctional peripheral T-lymphocytes. Mucosal, but not peripheral vaccination, provided substantial protection against Mtb infection, emphasizing the importance of delivery route for optimal efficacy.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Antibacterianos/farmacología , Lipopéptidos/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Sustancias Protectoras/farmacología , Adyuvantes Inmunológicos/síntesis química , Adyuvantes Inmunológicos/química , Antibacterianos/química , Antibacterianos/inmunología , Relación Dosis-Respuesta a Droga , Lipopéptidos/química , Lipopéptidos/inmunología , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Mycobacterium tuberculosis/inmunología , Sustancias Protectoras/síntesis química , Sustancias Protectoras/química , Relación Estructura-Actividad , Vacunación
14.
J Virol ; 93(22)2019 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-31462558

RESUMEN

Enteric viruses exploit bacterial components, including lipopolysaccharides (LPS) and peptidoglycan (PG), to facilitate infection in humans. Because of their origin in the bat enteric system, we wondered if severe acute respiratory syndrome coronavirus (SARS-CoV) or Middle East respiratory syndrome CoV (MERS-CoV) also use bacterial components to modulate infectivity. To test this question, we incubated CoVs with LPS and PG and evaluated infectivity, finding no change following LPS treatment. However, PG from Bacillus subtilis reduced infection >10,000-fold, while PG from other bacterial species failed to recapitulate this. Treatment with an alcohol solvent transferred inhibitory activity to the wash, and mass spectrometry revealed surfactin, a cyclic lipopeptide antibiotic, as the inhibitory compound. This antibiotic had robust dose- and temperature-dependent inhibition of CoV infectivity. Mechanistic studies indicated that surfactin disrupts CoV virion integrity, and surfactin treatment of the virus inoculum ablated infection in vivo Finally, similar cyclic lipopeptides had no effect on CoV infectivity, and the inhibitory effect of surfactin extended broadly to enveloped viruses, including influenza, Ebola, Zika, Nipah, chikungunya, Una, Mayaro, Dugbe, and Crimean-Congo hemorrhagic fever viruses. Overall, our results indicate that peptidoglycan-associated surfactin has broad viricidal activity and suggest that bacteria by-products may negatively modulate virus infection.IMPORTANCE In this article, we consider a role for bacteria in shaping coronavirus infection. Taking cues from studies of enteric viruses, we initially investigated how bacterial surface components might improve CoV infection. Instead, we found that peptidoglycan-associated surfactin is a potent viricidal compound that disrupts virion integrity with broad activity against enveloped viruses. Our results indicate that interactions with commensal bacterial may improve or disrupt viral infections, highlighting the importance of understanding these microbial interactions and their implications for viral pathogenesis and treatment.


Asunto(s)
Lipopéptidos/farmacología , Péptidos Cíclicos/farmacología , Peptidoglicano/metabolismo , Virus ARN/efectos de los fármacos , Animales , Línea Celular , Chlorocebus aethiops , Infecciones por Coronavirus/virología , Flaviviridae/efectos de los fármacos , Lipopéptidos/inmunología , Lipopéptidos/metabolismo , Coronavirus del Síndrome Respiratorio de Oriente Medio/metabolismo , Péptidos Cíclicos/inmunología , Péptidos Cíclicos/metabolismo , Peptidoglicano/genética , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/metabolismo , Síndrome Respiratorio Agudo Grave/virología , Células Vero , Virosis/metabolismo
15.
Front Immunol ; 10: 1372, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31258538

RESUMEN

Over fifty percent of the people around the world is infected with Helicobacter pylori (H. pylori), which is the main cause of gastric diseases such as chronic gastritis and stomach cancer. H. pylori adhesin A (HpaA), which is a surface-located lipoprotein, is essential for bacterial colonization in the gastric mucosa. HpaA had been proposed to be a promising vaccine candidate against H. pylori infection. However, the effect of non-lipidated recombinant HpaA (rHpaA) to stimulate immune response was not very ideal, and the protective effect against H. pylori infection was also limited. Here, we hypothesized that low immunogenicity of rHpaA may attribute to lacking the immunostimulatory properties endowed by the lipid moiety. In this study, two novel lipopeptides, LP1 and LP2, which mimic the terminal structure of the native HpaA (nHpaA), were synthesized and TLR2 activation activity was confirmed in vitro. To investigate whether two novel lipopeptides could improve the protective effect of rHpaA against the infection of H. pylori, groups of mice were immunized either intramuscularly or intranasally with rHpaA together with LP1 or LP2. Compared with rHpaA alone, the bacterial colonization of the mice immunized with rHpaA plus LP2 via intranasal route was significantly decreased and the expression levels of serum IgG2a, IFN-γ, and IL-17 cytokines in spleen lymphocyte culture supernatant increased obviously, indicating that the enhanced protection of LP2 may be associated with elevated specific Th1 and Th17 responses. In conclusion, LP2 has been shown to improve the protective effect of rHpaA against H. pylori infection, which may be closely related to its ability in activating TLR2 by mimicking the terminal structure of nHpaA.


Asunto(s)
Adhesinas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Infecciones por Helicobacter/inmunología , Helicobacter pylori/fisiología , Lipopéptidos/inmunología , Células TH1/inmunología , Células Th17/inmunología , Animales , Células Cultivadas , Femenino , Humanos , Inmunidad Innata , Interferón gamma/metabolismo , Interleucina-17/metabolismo , Lipopéptidos/síntesis química , Ratones , Ratones Endogámicos BALB C , Imitación Molecular , Receptor Toll-Like 2/inmunología
16.
J Immunol ; 202(12): 3349-3358, 2019 06 15.
Artículo en Inglés | MEDLINE | ID: mdl-31043477

RESUMEN

Similar to host proteins, N-myristoylation occurs for viral proteins to dictate their pathological function. However, this lipid-modifying reaction creates a novel class of "lipopeptide" Ags targeted by host CTLs. The primate MHC class I-encoded protein, Mamu-B*098, was previously shown to bind N-myristoylated 5-mer peptides. Nevertheless, T cells exist that recognize even shorter lipopeptides, and much remains to be elucidated concerning the molecular mechanisms of lipopeptide presentation. We, in this study, demonstrate that the MHC class I allele, Mamu-B*05104, binds the N-myristoylated 4-mer peptide (C14-Gly-Gly-Ala-Ile) derived from the viral Nef protein for its presentation to CTLs. A phylogenetic tree analysis indicates that these classical MHC class I alleles are not closely associated; however, the high-resolution x-ray crystallographic analyses indicate that both molecules share lipid-binding structures defined by the exceptionally large, hydrophobic B pocket to accommodate the acylated glycine (G1) as an anchor. The C-terminal isoleucine (I4) of C14-Gly-Gly-Ala-Ile anchors at the F pocket, which is distinct from that of Mamu-B*098 and is virtually identical to that of the peptide-presenting MHC class I molecule, HLA-B51. The two central amino acid residues (G2 and A3) are only exposed externally for recognition by T cells, and the methyl side chain on A3 constitutes a major T cell epitope, underscoring that the epitopic diversity is highly limited for lipopeptides as compared with that for MHC class I-presented long peptides. These structural features suggest that lipopeptide-presenting MHC class I alleles comprise a distinct MHC class I subset that mediates an alternative pathway for CTL activation.


Asunto(s)
Autoantígenos/metabolismo , Epítopos de Linfocito T/metabolismo , Productos del Gen nef/metabolismo , Antígenos de Histocompatibilidad Clase I/metabolismo , Lipopéptidos/metabolismo , Péptidos/metabolismo , Linfocitos T Citotóxicos/inmunología , Animales , Presentación de Antígeno , Autoantígenos/química , Autoantígenos/inmunología , Cristalografía por Rayos X , Epítopos de Linfocito T/inmunología , Productos del Gen nef/química , Productos del Gen nef/inmunología , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Lipopéptidos/química , Lipopéptidos/inmunología , Activación de Linfocitos , Ácido Mirístico/química , Péptidos/química , Péptidos/inmunología , Filogenia , Primates
17.
Microbes Infect ; 21(7): 328-335, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30817996

RESUMEN

The use of adjuvants in vaccine formulations is a well-established practice to improve immunogenicity and protective immunity against diseases. Previously, we have demonstrated the feasibility of intranasal vaccination with the antigen of killed Leishmania amazonensis promastigotes (LaAg) against experimental leishmaniasis. In this work, we sought to optimize the immunogenic effect and protective immunity against murine visceral leishmaniasis conferred by intranasal delivery of LaAg in combination with a synthetic TLR1/TLR2 agonist (Pam3CSK4). Intranasal vaccination with LaAg/PAM did not show toxicity or adverse effects, induced the increase of delayed-type hypersensitivity response and the production of inflammatory cytokines after parasite antigen recall. However, mice vaccinated with LaAg/PAM and challenged with Leishmania infantum presented significant reduction of parasite burden in both liver and spleen, similar to those vaccinated with LaAg. Although LaAg/PAM intranasal vaccination had induced higher frequencies of specific CD4+ and CD8+ T cells and increased levels of IgG2a antibody isotype in serum, both LaAg and LaAg/PAM groups presented similar levels of IL-4 and IFN-y and decreased production of IL-10 when compared to controls. Our results provide the first evidence of the feasibility of intranasal immunization with antigens of killed Leishmania in association with a TLR agonist, which may be explored for developing an effective and alternative strategy for vaccination against visceral leishmaniasis.


Asunto(s)
Antígenos de Protozoos/inmunología , Leishmania/inmunología , Vacunas contra la Leishmaniasis/inmunología , Leishmaniasis Visceral/inmunología , Lipopéptidos/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Administración Intranasal , Animales , Anticuerpos Antiprotozoarios/sangre , Antígenos de Protozoos/administración & dosificación , Citocinas/sangre , Femenino , Vacunas contra la Leishmaniasis/administración & dosificación , Leishmaniasis Visceral/parasitología , Leishmaniasis Visceral/prevención & control , Lipopéptidos/administración & dosificación , Hígado/metabolismo , Hígado/parasitología , Linfocitos/inmunología , Ratones Endogámicos BALB C , Óxido Nítrico/metabolismo , Bazo/metabolismo , Bazo/parasitología , Vacunación
18.
Immunobiology ; 224(1): 1-9, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30509503

RESUMEN

Toll-like receptor 2 (TLR2) is currently investigated as a potential therapeutic target in diseases with underlying inflammation like sepsis and arthritis. We reported the discovery, by virtual screening and biological testing, of eight TLR2 antagonists (AT1-AT8) which showed TLR2-inhibitory activity in human cells (Murgueitio et al., 2014). In this study, we have deepened in the mechanism of action and selectivity (TLR2/1 or TLR2/6) of those compounds in mouse primary cells and in vivo. The antagonists reduced, in a dose-dependent way the TNFα production (e.g. AT5 IC50 7.4 µM) and also reduced the nitric oxide (NO) formation in mouse bone marrow-derived macrophages (BMDM). Treatment of BMDM with the antagonists showed that downstream of TLR2, MAPKs phosphorylation and IkBα degradation was reduced. Notably, in a mouse model of tri-acylated lipopeptide (Pam3CSK4)-induced inflammation, AT5 attenuated the TNFα and IL-6 inflammatory response. Further, the effect of AT5 in the stimulation of BMDM by the endogenous alarmin HMGB1 was investigated. Our results indicate that AT4-AT7 and, particularly AT5 appear as good starting points for the development of inhibitors targeting TLR2 in inflammatory disorders.


Asunto(s)
Antiinflamatorios/farmacología , Macrófagos/efectos de los fármacos , Sepsis/tratamiento farmacológico , Receptor Toll-Like 2/antagonistas & inhibidores , Animales , Células HEK293 , Proteína HMGB1/metabolismo , Humanos , Lipopéptidos/inmunología , Macrófagos/inmunología , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico/metabolismo , Células RAW 264.7 , Factor de Necrosis Tumoral alfa/inmunología
19.
Dev Comp Immunol ; 91: 115-122, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30389519

RESUMEN

Toll-like receptors (TLRs) are a group of sensory receptors which are capable of recognizing a microbial invasion and activating innate immune system responses, including inflammatory responses, in both immune and non-immune cells. However, TLR functions in chick myoblasts, which are myogenic precursor cells contributing to skeletal muscle development and growth, have not been studied. Here, we report the expression patterns of TLR genes as well as TLR ligand-dependent transcriptions of interleukin (IL) genes in primary-cultured chick myoblasts. Almost TLR genes were expressed both in layer and broiler myoblasts but TLR1A was detected only in embryonic layer chick myoblasts. Chick TLR1/2 ligands, Pam3CSK4 and FSL-1, induced inflammatory ILs in both layer and broiler myoblasts but a TLR4 ligand, lipopolysaccharide, scarcely promoted. This is the first report on TLR ligand-dependent inflammatory responses in chick myoblasts, which may provide useful information to chicken breeding and meat production industries.


Asunto(s)
Proteínas Aviares/metabolismo , Enfermedades de las Aves/inmunología , Pollos/inmunología , Inflamación/inmunología , Músculo Esquelético/fisiología , Mioblastos/fisiología , Animales , Embrión de Pollo , Diglicéridos/inmunología , Regulación del Desarrollo de la Expresión Génica , Inmunidad Innata , Lipopéptidos/inmunología , Lipopolisacáridos/inmunología , Oligopéptidos/inmunología , Receptores Toll-Like/metabolismo , Transcriptoma
20.
Front Immunol ; 9: 2768, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30581431

RESUMEN

Adequate perception of immunologically important pathogen-associated molecular patterns like lipopolysaccharide and bacterial lipoproteins is essential for efficient innate and adaptive immune responses. In the context of Gram-negative infection, bactericidal/permeability-increasing protein (BPI) neutralizes endotoxic activity of lipopolysaccharides, and thus prohibits hyperactivation. So far, no immunological function of BPI has been described in Gram-positive infections. Here, we show a significant elevation of BPI in Gram-positive meningitis and, surprisingly, a positive correlation between BPI and pro-inflammatory markers like TNFα. To clarify the underlying mechanisms, we identify BPI ligands of Gram-positive origin, specifically bacterial lipopeptides and lipoteichoic acids, and determine essential structural motifs for this interaction. Importantly, the interaction of BPI with these newly defined ligands significantly enhances the immune response in peripheral blood mononuclear cells (PBMCs) mediated by Gram-positive bacteria, and thereby ensures their sensitive perception. In conclusion, we define BPI as an immune enhancing pattern recognition molecule in Gram-positive infections.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/inmunología , Proteínas Bacterianas/inmunología , Proteínas Sanguíneas/inmunología , Bacterias Grampositivas/inmunología , Infecciones por Bacterias Grampositivas/inmunología , Lipoproteínas/inmunología , Meningitis Bacterianas/inmunología , Infecciones por Bacterias Grampositivas/patología , Células HEK293 , Humanos , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/patología , Lipopéptidos/inmunología , Lipopolisacáridos/inmunología , Masculino , Meningitis Bacterianas/patología , Ácidos Teicoicos/inmunología , Factor de Necrosis Tumoral alfa/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...